[
    [
        {
            "time": "2018-03-15",
            "original_text": "This Pharma Wants To Scoop Its Rivals With An Oral Diabetes Med",
            "features": {
                "keywords": [
                    "Pharma",
                    "oral diabetes med",
                    "rivals"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "This Pharma Wants To Scoop Its Rivals With An Oral Diabetes Med",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2019-06-20",
            "original_text": "CORRECTED-Oral Novo Nordisk diabetes drug poses no more heart risk than placebo -study",
            "features": {
                "keywords": [
                    "Novo Nordisk",
                    "diabetes drug",
                    "heart risk",
                    "placebo"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "CORRECTED-Oral Novo Nordisk diabetes drug poses no more heart risk than placebo -study",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2020-04-10",
            "original_text": "UPDATE 2-China stimulus, German rally help European stock end higher",
            "features": {
                "keywords": [
                    "China stimulus",
                    "German rally",
                    "European stock",
                    "end higher"
                ],
                "sentiment_score": 0.9,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "economy",
                    "finance"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "UPDATE 2-China stimulus, German rally help European stock end higher",
                "Correlation": 4,
                "Sentiment": 6,
                "Importance": 5,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 3,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        }
    ]
]